Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications: Current State of the Art and Opportunities to Advance the Science.
Featured Topics Include:
• Type 2 Diabetes: Clinical implications, CV manifestations, and epidemiology
• Therapies and targets for treatment of Diabetes Mellitus – potential implications on CV safety
• Glycemic control – evidence for positive and negative impacts on CV and renal outcomes in Type 2 DM
• New trial design approaches to assessing CV Safety
• The clinical evidence that T2DM diabetic drugs can increase CV risk and potential mechanisms
• Diabetic drug development and CV safety
• Approaches to Clinical Analysis of CV Risk
• Novel Clinical Trial Approaches
• Future Approaches to Assessing T2DM Drug Development and CV Safety
• QT experience as a model for furthering collaborative approaches/research in CV-Safety assessment of T2DM agents